Synthetic anti-cholinesterases or AChE inhibitors such as galantamine, donepezil, memantine, rivastigmine, tacrine, and physostigmine are currently known drugs for the management of AD (Js et al., 2015). This evidence concerns the gene ACHE and Alzheimer disease.